BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Revenue | 1.57M | 1.83M | 2.19M | 2.49M | 2.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.57M | 1.83M | 2.19M | 2.49M | 2.79M |
| Cost of Revenue | 506.00K | 616.00K | 747.00K | 856.00K | 955.00K |
| Gross Profit | 1.06M | 1.21M | 1.44M | 1.63M | 1.83M |
| SG&A Expenses | 3.91M | 4.30M | 5.07M | 5.71M | 6.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.14M | 6.77M | 7.93M | 8.75M | 9.75M |
| Operating Income | -4.57M | -4.94M | -5.74M | -6.27M | -6.96M |
| Income Before Tax | -5.30M | -5.72M | -7.09M | -7.23M | -8.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.30 | -5.72 | -7.09 | -7.23 | -8.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.30M | -5.72M | -7.09M | -7.23M | -8.07M |
| EBIT | -4.57M | -4.94M | -5.74M | -6.27M | -6.96M |
| EBITDA | -4.48M | -4.84M | -5.63M | -6.14M | -6.83M |
| EPS Basic | -0.74 | -0.81 | -0.82 | -0.84 | -1.00 |
| Normalized Basic EPS | -0.36 | -0.40 | -0.48 | -0.50 | -0.60 |
| EPS Diluted | -0.74 | -0.81 | -0.82 | -0.84 | -1.00 |
| Normalized Diluted EPS | -0.36 | -0.40 | -0.48 | -0.50 | -0.60 |
| Average Basic Shares Outstanding | 38.42M | 35.77M | 34.52M | 34.34M | 32.68M |
| Average Diluted Shares Outstanding | 38.42M | 35.77M | 34.52M | 34.34M | 32.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
